Biostar Pharmaceuticals To Announce 2012 Third Quarter Financial Results And
Conduct Conference Call On Monday, November 19th
XIANYANG, China, Nov. 16, 2012
XIANYANG, China, Nov. 16, 2012 /PRNewswire/ -- Biostar Pharmaceuticals, Inc.
(NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and
marketer of pharmaceutical and health supplement products in China for a
variety of diseases and conditions, today announced that it will issue its
financial results for the third quarter ended September 30, 2012 on Monday,
November 19, 2012 before the open of the market, well within the Quarterly
Report filing extension permitted under the applicable rules and regulations.
Biostar's Chairman and CEO, Ronghua Wang and CFO, Zack Pan will host a
conference call on Monday, November 19, 2012 at 9:30 am ET / 10:30 pm China
time to discuss these results as well as recent corporate developments.
Live conference call details
Interested parties may participate in the call by dialing (480) 629-9712.
Please call in 10 minutes before the conference is scheduled to begin and ask
for the Biostar call or use pass code 4576907. After opening remarks, there
will be a question and answer period. Questions may be asked during the live
call, or alternatively, you may e-mail questions in advance to
The conference call will also be broadcast live over the Internet. To listen
to the webcast, please go to http://public.viavid.com/index.php?id=102669 or
visit Biostar's website http://www.biostarpharmaceuticals.com and then to the
Event Calendar page where the conference call is posted. Please go to the
website at least 15 minutes early to register, and download and install any
necessary audio software. If you are unable to listen live, the conference
call will be archived and can be accessed for approximately 90 days. We
suggest listeners use Microsoft Internet Explorer as their web browser.
A replay will be available until 11:59 pm E.T. on November 26, 2012. To
listen, please call (858) 384-5517 and use pass code 4576907.
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and
controlled affiliate in China, develops, manufactures and markets
pharmaceutical and health supplement products for a variety of diseases and
conditions. The Company's most popular product is its Xin Ao Xing Oleanolic
Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a
disease affecting approximately 10% of the Chinese population. For more
information please visit: http://www.biostarpharmaceuticals.com.
For more information contact:
Biostar Pharmaceuticals, Inc. The Equity Group Inc.
Zack Pan, CFO Lena Cati
Tel: 405-996-8829 Tel: 212 836-9611
Email: firstname.lastname@example.org Email: email@example.com
SOURCE Biostar Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.